Skip to contentU
Ultralife Corp
U
ULBIUltralife Corp Q4 2021 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$23.76M$23.76Mderived−18.0% vs Q4 2020 Net Income-$1.13M-$1.13MderivedN/M vs Q4 2020 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Ultralife Corp · CIK 875657 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$5,289,000−28.1% Operating Incomederived-$1,229,000N/M Operating Cash Flowderived-$4,137,000N/M Free Cash Flowderived-$4,627,000N/M Margins · derivedGross margin22.3%−3.1 pt vs Q4 2020
Operating margin-5.2%−9.4 pt vs Q4 2020
Net margin-4.8%−12.0 pt vs Q4 2020
ended Dec 31, 2021 · filed Mar 8, 2022 · 67 d after period end